Study shows efficacy of Endocare CELLPRO
Published
10th Jul 2017
A study has been published in the Journal of Drugs in Dermatology showing the efficacy of the Endocare CELLPRO range (AesthetiCare).
The Endocare range rejuvenates skin by bringing together stem cell activators and growth factors, with vitamins A and C.
The study by Dr Hema Sundaram, entitled “The Mechanisms and Potential Impact of Stem Cell Activation in Skin Rejuvenation: An Evidence-Based Analysis” investigated the potential impact of stem cell activators on skin rejuvenation. She discovered that CAF BioAction, unique to the CELLPRO range, is clinically proven to activate the skin’s existing stem cells, causing them to generate new fibroblasts.